Faculty profile
Hasan Uludag
Back to facultyThis profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Alberta directory, so their courses may be missing. Find their university profile.
Research
Latest papers
Cationic lipopolymer based siRNA delivery for experimental lung cancer treatment.
Biomaterials advances · 2025 · senior author
Delivery Aspects for Implementing siRNA Therapeutics for Blood Diseases.
Biochemistry · 2024 · senior author
Corrigendum to "The effect of low intensity pulsed ultrasound on mandibular condylar growth in young adult rats" [Bone Rep. 15 (2021) 101122 (December)].
Bone reports · 2023
Latest funding
- $250,000
Precision Medicine for Autoinflammatory Disorders
SSHRC · 2023 · Principal investigator
- $100,000
New Treatment of Blood Cancers with Improved Delivery of Nucleic Acids
CIHR · 2022 · Nominated PI
- $250,000
Priming Immune Cells for Genetic Modification
SSHRC · 2020 · Principal investigator
39 publications.
Cationic lipopolymer based siRNA delivery for experimental lung cancer treatment.
Kc R, Nasrullah M, Sandhu G, Kucharski C, Lavasanifar A, Uludag H
Delivery Aspects for Implementing siRNA Therapeutics for Blood Diseases.
Abbasi Dezfouli S, Michailides ME, Uludag H
Corrigendum to "The effect of low intensity pulsed ultrasound on mandibular condylar growth in young adult rats" [Bone Rep. 15 (2021) 101122 (December)].
Hadaegh Y, Uludag H, Dederich D, El-Bialy TH
Designing Nanomedicines for Breast Cancer Therapy.
Abbasi Dezfouli S, Rajendran AP, Claerhout J, Uludag H
Nanoparticles and cytokine response.
Nasrullah M, Meenakshi Sundaram DN, Claerhout J, Ha K, Demirkaya E, Uludag H
Editorial: Bio and nanomaterials in tissue engineering and regenerative medicine (BioNTERM).
Alarcon EI, Uludag H, Griffith M, Mantovani D
Potential of siRNA in COVID-19 therapy: Emphasis on in silico design and nanoparticles based delivery.
Fopase R, Panda C, Rajendran AP, Uludag H, Pandey LM
Safe and Effective Delivery of mRNA Using Modified PEI-Based Lipopolymers.
Wang H, Liu X, Ai X, Remant-Bahadur KC, Dick TA, Yan B, Lu T, Zhou X, Luo R, Liu M, Wang X, Li K, Wang W, Uludag H, Fu W
siRNA Functionalized Lipid Nanoparticles (LNPs) in Management of Diseases.
Kalita T, Dezfouli SA, Pandey LM, Uludag H
The effect of low intensity pulsed ultrasound on mandibular condylar growth in young adult rats.
Hadaegh Y, Uludag H, Dederich D, El-Bialy TH
Precision Medicine for Autoinflammatory Disorders
Principal investigators: Uludag, Hasan
Keywords: genetic and molecular therapy; autoimmunity; drug delivery; nucleic acids; RNAi; CRISPR; cytokine disorders
New Treatment of Blood Cancers with Improved Delivery of Nucleic Acids
Principal investigators: Uludag, Hasan
Keywords: Animal Model; Cancer Therapy; Efficacy; Leukemia; Manufacturing; Nanomaterials; Polymeric Biomaterials; Process Chemistry; Safety; Sirna
Priming Immune Cells for Genetic Modification
Principal investigators: Uludag, Hasan
Synthetic Biomaterials to Package and Deliver siRNA Nanoparticles in order to Curb Uncontrolled Growth of Leukemic Cells
Principal investigators: Uludag, Hasan
Keywords: Amphiphilic Polymers; Animal Model; Anti-Cancer Therapy; Drug Resistance; Leukemia; Molecular Therapy; Nanoparticles; Patient Derived Cells; Polymeric Biomaterials; Sirna Delivery
Engineering Effective Polymers to Enable Gene Based Therapies
Principal investigators: Uludag, Hasan
Ultrasound technology to improve transfection of human cells
Principal investigators: Uludag, Hasan
Engineering Biomimetic Gene Activated Matrices for Bone Tissue Regeneration
Principal investigators: Uludag, Hasan
Keywords: Animal Model; Biomimetic; Bone Regeneration; Gene Therapy; Mineralization; Osteogenesis; Osteoprogenitor Cells; Scaffold
Technology To Improve the Robustness of Diagnostic Assays
Principal investigators: Uludag, Hasan
siRNA Therapy for Leukemia: Synthetic Biomaterials to Deliver siRNA and Curb Uncontrolled Growth of Leukemic Cells
Principal investigators: Uludag, Hasan
Keywords: Animal Models; Drug Delivery; Leukemia; Leukemic Stem Cells; Non-Viral Drug Delivery; Pharmacodynamics; Pharmacokinetics; Polymeric Biomaterials; Sirna Delivery; Synthetic Lethality
Nanodelivery Systems for Modulation of Chemotherapy Response in Invasive and Metastatic Breast Cancer
Principal investigators: Lavasanifar, Afsaneh
Keywords: Cancer Chemotherapy; Drug Delivery; Drug Resistance; Nanotechnology; Sirna Delivery; Targeted Therapy
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
Frequent collaborators
- Chemical and Materials Engineering
- Terry Fox Laboratory
- Surgery
- Laboratory Medicine and Pathology
- Pharmacologie - Physiologie
- Oncology
- Mike Petryk School of Dentistry
- Other
Co-authors at University of Alberta, colored by department. Thicker lines mean more shared papers; select anyone to open their profile and their own map.
Afsaneh Lavasanifar
Faculty
5 shared papers, latest 2025
Xiaoyan Jiang
Terry Fox Laboratory
2 shared papers, latest 2018
Locksley Mcgann
Laboratory Medicine and Pathology
1 shared papers, latest 2005
Michael Weinfeld
Oncology
1 shared papers, latest 2007
Adetola Adesida
Surgery
1 shared papers, latest 2013
May Griffith
Pharmacologie - Physiologie
1 shared papers, latest 2023
Xiaoli Pang
Laboratory Medicine & Pathobiology
1 shared papers, latest 2011
Tarek El-Bialy
Mike Petryk School of Dentistry
1 shared papers, latest 2010
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.